Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1154559rdf:typepubmed:Citationlld:pubmed
pubmed-article:1154559lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1154559lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:1154559lifeskim:mentionsumls-concept:C0600139lld:lifeskim
pubmed-article:1154559lifeskim:mentionsumls-concept:C0032176lld:lifeskim
pubmed-article:1154559lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:1154559lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:1154559pubmed:issue3lld:pubmed
pubmed-article:1154559pubmed:dateCreated1975-11-1lld:pubmed
pubmed-article:1154559pubmed:abstractTextIn patients with carcinoma of the prostate treated with estrogens platelet aggregation is increased. Patients with increased platelet aggregation have a high incidence of cardio-vascular and thrombo-embolic diseases. Platelet aggregation was measured by the platelet-aggregation test (PAT). Platelet aggregation was inhibited by administration of acetyl-salicylic acid (ASS) 2 times 500 mg daily. An aggregation inhibiting effect was found in all 38 patients. To reduce the cardio-vascular complications of estrogens in treating carcinoma of the prostate acetyl-salicylic acid as an adjunct therapy is recommended. A long-term study has been started.lld:pubmed
pubmed-article:1154559pubmed:languagegerlld:pubmed
pubmed-article:1154559pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1154559pubmed:citationSubsetIMlld:pubmed
pubmed-article:1154559pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1154559pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1154559pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1154559pubmed:statusMEDLINElld:pubmed
pubmed-article:1154559pubmed:monthMaylld:pubmed
pubmed-article:1154559pubmed:issn0340-2592lld:pubmed
pubmed-article:1154559pubmed:authorpubmed-author:EisenMMlld:pubmed
pubmed-article:1154559pubmed:authorpubmed-author:NappH EHElld:pubmed
pubmed-article:1154559pubmed:authorpubmed-author:VockRRlld:pubmed
pubmed-article:1154559pubmed:issnTypePrintlld:pubmed
pubmed-article:1154559pubmed:volume14lld:pubmed
pubmed-article:1154559pubmed:ownerNLMlld:pubmed
pubmed-article:1154559pubmed:authorsCompleteYlld:pubmed
pubmed-article:1154559pubmed:pagination132-6lld:pubmed
pubmed-article:1154559pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:meshHeadingpubmed-meshheading:1154559-...lld:pubmed
pubmed-article:1154559pubmed:year1975lld:pubmed
pubmed-article:1154559pubmed:articleTitle[Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].lld:pubmed
pubmed-article:1154559pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1154559pubmed:publicationTypeEnglish Abstractlld:pubmed